NCT05974267: Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)
- State
- Completed
- Phase
- Phase 2
- People
- 192 taking part
- Started
- 28 Nov 2023
- Primary completion
- 29 Dec 2024
- Arms
- Cohort 2: M5717 (200 mg) + Pyronaridine
- Results
- Posted on the registry
- 3 Aug 2023: Trial registered
- 28 Nov 2023: Trial started
- 29 Dec 2024: Trial completed
- 6 Feb 2026: Trial results posted